Tag
Alkem Laboratories Limited
4 articles
Alkem Laboratories Schedules Sprucegrove Investor Meeting
Alkem Laboratories intimates a one-on-one in-person meeting with Sprucegrove Investments in Mumbai on July 6, 2026.
The disclosure is a regulatory filing made to BSE and NSE in compliance with SEBI LO
Alkem Laboratories Schedules TA Associates Virtual Meeting
Alkem Laboratories intimates NSE/BSE about a scheduled virtual analyst meeting with TA Associates on July 3, 2026.
The disclosure is made pursuant to SEBI LODR Regulations 2015 requirements for invest
Alkem Medtech Executes Occlutech Acquisition Supplementary Agreement
Alkem Laboratories subsidiary Alkem Medtech executed a First Supplementary Agreement to its Share Purchase Agreement for Occlutech Holding AG acquisition.
The agreement, dated June 26, 2026, modifies
Samprada & Nanhamati Trust Sells 0.46% Alkem Stake
Samprada and Nanhamati Singh Family Trust disclosed sale of 0.46% stake in Alkem Laboratories on June 2, 2026.
Trust's shareholding reduced from 18.74% to 18.28% following the transaction and distribu